Trivitron Healthcare launches its state-of-the-art Ultisys – Digital Radiography System at Arab Health 2017, Dubai

30th January, 2017 - Kiran Medical Systems, the radiology division of Trivitron Healthcare, introduced its innovation driven Ultisys range of radiography products during the Arab Health Convention in Dubai. The Ultisys system offers an affordable yet versatile platform for a wide range of clinical applications involving general radiography. The Ultisys system features a floor mounted x-ray system with a wide range of generator power options from 32 kW to 82 kW, choice of tethered or wireless flat panel detectors. And the entire system seamlessly integrated through a powerful imaging software platform that provides a highly intuitive user interface and image processing that makes even the smallest bone and soft tissue details visible in superb resolution.

 From left to right-Dr GSK Velu, Chairman & Managing Director, Trivitron Healthcare and Mr. Satyaki Banerjee, President, Kiran Medical Systems

One of the many Radiology products launched today

Kiran’s portfolio of radiology products includes the Infinity and Elite series surgical C-Arm systems available in 3.5kW and 5.0kW power output and the option of 1Kx1K digital imaging chain with advanced image processing capabilities; a comprehensive range of Radiation Protection Products, Anti-scatter x-ray grids and Imaging Accessories including Computed Radiography systems, Dry Films for DICOM printers, Screen Films, Analogue Cassettes and Screens.

The manufacturing facilities of Kiran comply with the most stringent quality standards and are approved by US-FDA, SGS-UK and PMDA-Japan amongst others.

Kiran’s range of radiology equipment is made cost-effective for the Indian market by adhering to the company’s inherent philosophy of ‘Make in India’. With approximately 50-65% of the entire raw materials/ components designed and manufactured from scratch in India, there is a significant cost reduction in the development of the equipment subsequently enabling the brand to make the products available at affordable prices. This also helps in leveraging local technological expertise and entrepreneurial mindset for the global market thereby promoting Indian products and solutions designed to increase efficiency at reduced costs in an international level.  With Kiran’s newly launched radiology equipment made available in this market, smaller hospitals and diagnostic centers which could not avail high-end radiology technology earlier will now be able to install up to-date radiology machines within their means.

Speaking on the occasion Mr. Satyaki Banerjee, President of Kiran Medical Systems commented, “Kiran is committed to the field of radiology and has been focusing extensively on research and development to develop smart-practical products that offer incredible clinical functionality at an affordable cost. The Ultisys Direct Radiography system is the first of wide range of product launches planned in 2017, which would include mobile x-ray and digital mammography systems. Kiran has a strong legacy of manufacturing high quality radiology accessories and radiation protection products and the equipment portfolio further strengthens Kiran’s presence and market share in this segment. The Ultysis platform has been indigenously designed and developed by Trivitron’s Kiran Research and Development team and a major portion of the components are manufactured in-house in addition to final integration of the system, in keeping with Prime Minister Mr. Narendra Modi’s Make in India Initiative.”

Commenting on this development Dr. GSK Velu, Chairman and Managing Director, Trivitron Group of Companies said, “2017 will be defining the 20th year Journey for Trivitron and its continuous pursuit to Innovate and Provide Medical Technology Products, Services and Solutions to make Healthcare Affordable and Accessible to everyone across the Globe. We have progressed substantially in Research and Development and manufacturing with 9 state of the art facilities spread across the globe in India, Turkey and Finland. Kiran, the radiology division of the Trivitron group has been entrusted with the responsibility of developing a full suite of products to make superior quality digital radiography accessible to all and the launch of the Ultisys system is a pivotal milestone in this journey.”

About Trivitron Healthcare:

The genesis of Trivitron Healthcare Private Limited, dates back to 1997, when Dr. Velu, a first generation entrepreneur decided to build a company on the premise of delivering cost-effective medical technology solutions and services to the underserved. Today, Trivitron Healthcare, through successful inorganic synergies with local and global firms, and is the largest medical technology company of Indian origin, with products exported to over 165 countries.

Read More »

LABSYSTEMS DIAGNOSTICS & SHIMADZU CORPORATION IN A STRATEGIC ALLIANCE FOR NEWBORN SCREENING

Bangalore, 7 September, 2016 – Labsystems Diagnostics, Helsinki, an enterprise of Trivitron Healthcare, the fast growing healthcare multinational headquartered in Chennai, entered into a Joint Association with Shimadzu Corporation, Japan, leader in analytical instruments, for clinical diagnostics in the area of Newborn Screening (NBS). NBS is a preventive pediatric screening service to assess the occurrence of genetic metabolic disorders. These disorders could lead to permanent neurological, cognitive, and physical damage in the child.  When these disorders are detected early enough they can be easily treated.

The companies will cooperate to leverage Labsystems reagent technology leadership and Shimadzu world class instrumentation to enable their global customer base to detect more disorders in newborns, more rapidly and with greater accuracy. 

Labsystems furthermore announces the availability of its new generation NeoMass AAAC assay fully validated on Shimadzu mass spectrometry platforms. NeoMass AACC enables investigators for the first time to detect the entire spectrum of Urea Cycle Metabolic Disorders (UCMD) in newborns.  This assay detects the broadest range of non derivatized analytes available today.

Fabrizio RADICE, Global Sales & Mktg Director, Labsystems Diagnostics, Helsinki commented “Our alliance with Shimadzu will enable us to develop unparalleled integrated solutions for NBS, of which NeoMass AACC is only the start.  Co-development on this level allows us to leverage the impressive technology leadership of Shimadzu instrumentation to provide sensitivity to new disorders, and to provide faster throughput and greater accuracy, which is the key to investigators success in detecting disorders in babies.  We believe our cooperation will have an impact on the suffering caused by these severe, yet eminently preventable diseases”.

Dr. Geraldine Carrard, CEO – Labsystems Diagnostics Oy added, “The deliberations and discussions have paved the way of a trusted and solid partnership. Shimadzu Trivitron Labsystems Diagnostics combination will be an innovative driving force to reckon within the Newborn Screening.”

Shuzo Maruyama, General Manager, Analytical & Measuring Instruments Division Shimadzu Corporation said ‘The agreement between Shimadzu Corporation and LabSystems Diagnostics will help to change the way in new born screening programs can be better, expanding the screening capability with detailed analytics and actionable data creating a new solution for faster, confident diagnosis. Shimadzu is always exploring ways to find a solution that meets a real need and makes a difference to overcome real world challenges. We believe this collaboration with LabSystems Diagnostics will help make smart decisions quicker and will make clinical laboratories more efficient and effective in new born screening’. 

Dr. G.S.K. Velu, Chairman & Managing Director, Trivitron Group of Companies said, “Two world leaders Shimadzu and Labsystems Diagnostics with several decades of expertise in their respective areas of instrumentation and diagnostic reagents will create a winning combination improving access and affordability for Newborn Screening solutions across the globe. We are very excited with this new global association in the New Born Screening area.”

About Trivitron Healthcare Labsystems Diagnostics: 

Trivitron Healthcare is a globally acclaimed healthcare technology solution company headquartered in Chennai, India. Trivitron Healthcare strives to make healthcare technology accessible to all. Trivitron Healthcare offers solutions in laboratory medicine, Radiology, Radiology protection, Cardiology, OR, ICU, renal care, Newborn Screening. 

Labsystems Diagnostics is proud to be part of the Trivitron group of companies since 2012.  Labsystems has been a forerunner in innovative diagnostic research and development for the last 30 years. Labsystems Diagnostics is committed to develop high quality diagnostic solutions for clinical and research laboratories, and for consumer use. The company is dedicated to R&D investment, developing highly qualified personnel and state of the art production. A highly rigorous quality system and CE-marked products ensure sustainable quality of the products. These assets combined with efficient customer support have meant long term customer satisfaction and a solid reputation for success. Within 30 years of experience, Labsystems Diagnostics has been a key pioneer in IVD space and Newborn screening.

A track record of technology leadership: Labsystems has long been a pioneer in the Detection of Metabolic Diseases; first to develop fluorometric PKU (Phenylketonuria) tests for NBS, first to provide PKU assays in micro-plate format, and first to combine high throughput fluorescence tests for both PKU and TSH (thyroid-stimulating hormone). Labsystems’ innovative NS2400 fully automated high throughout system for NBS has enabled fully automated screening in high-throughput laboratories, Labsystems Diagnostics has an extensive R&D pipeline of over 35 products under development.

About Shimadzu Corporation:

Founded in 1875, Shimadzu Corporation, a leader in the development of advanced technologies, has a distinguished history of innovation built on the foundation of contributing to society through science and technology. Shimadzu maintains a global network of sales, service, technical support and applications centers on six continents, and has established long-term relationships with a host of highly trained distributors located in over 100 countries.

Read More »

TRIVITRON HEALTHCARE ACQUIRES MAJOR STAKE IN TURKISH HEALTHCARE FIRM

New Delhi, 11th July 2016: Trivitron Healthcare, one of India's largest medical technology companies of Indian origin has announced the acquisition of 60 per cent stake in Turkish healthcare firm Bome Sanayi Urunleri Dis. Tic. Ltd Sti. The remaining 40 per cent stake in the In-Vitro Diagnostic (IVD) device manufacturing firm will be held by the promoters.  

With this acquisition, Trivitron will have direct access to the Turkish, Middle Eastern, African, South and South East Asian Markets. Trivitron expects significant growth in the region as it will have access to Bome’s production facility, research labs and New Born Screening Laboratory. The company now have nine manufacturing facilities located in India, Finland and Turkey.

Bome Sanayi is one of the first to foray into In-Vitro Diagnostic (IVD) device manufacturing in Turkey. The products of the company are marketed under the brand name Trimaris and exported to Portugal, Syria, Egypt, Iraq, Sudan and Kenya. “Besides, Bome has 100 per cent market share in New Born Screening Tests by screening over 1.8 million babies and 10 Million tests per year in Turkey,” said Trivitron Chairman and Managing Director Dr. G.S.K. Velu. The Bome production facility is located at Ostim, Ankara in Turkey with labs located in Ankara and Istanbul. Current production lines include new born screening tests, hematology solutions, clinical chemistry reagents, rapid urease tests, coagulation reagents and sterile & non-sterile deionized water etc.   

“We have invested five million euros for picking up the stake including share premium. This acquisition brings in growth capital and distribution network for Bome who have been active in diagnostics since 1989 and have been conducting New Born Screening Tests for the last eight years on behalf of the Government of Turkey. Through this acquisition, Trivitron will acquire Bome’s expertise on running low-cost New Born Screening programs in Public Private Partnership mode. India is yet to start the organized Universal New Born Screening and having Bome in our fold will be an added advantage to Trivitron Group,” said Dr Velu. 

He also added, “Trivitron will now have access to produce IVD Diagnostics Kits using Finnish (fluorescent /mass spectrometry) and Turkish (Elisa) techniques in France, Turkey and India. Finnish product is good for hi-end testing and Turkey for the mass market. In India, the commercial production will be commencing soon for these products using Finnish technology. The company will now have access to lot of R&D funding in Turkey too. Besides, we will also get incentives from the Turkish government for making in Turkey. New Born Screening is a compulsory government programme in Turkey and Trivitron will showcase the programme to the Indian government with a focus on Public Private Partnership and pay-per-baby model. A universal New Born Screening program like this on a PPP model with various state governments supported by a Make In India initiative will substantially help the 26 Million babies born every year in India.”

The founder of Bome Sanayi Urunleri Dis. Tic. Ltd Mr. Mehmet Demirel had 55 per cent stake in the company, CEO Gulsah Sonmez had 20 per cent and Zeynep Demirel 20 per cent. The company reported a sales turnover of 22 million lira, approximately 50 crores.

About Trivitron Healthcare:

The genesis of Trivitron Healthcare Private Limited, dates back to 1997, when Dr. Velu, a first generation entrepreneur decided to build a company on the premise of delivering cost-effective medical technology solutions and services to the underserved. Today, Trivitron Healthcare, through successful inorganic synergies with local and global firms, has a revenue turnover of 700+ crores, and is the largest medical technology company of Indian origin, with products exported to over 165 countries.

Read More »

Kiran Medical Systems showcases state-of-the-art C-Arm systems along with its wide portfolio of radiology products at Arab healthcare 2016

 January 25 2016,  13.35 PM IST || Pocket Press Release

25th, January 2016 - Kiran Medical Systems, the radiology division of Trivitron Healthcare, showcased its state-of-the-art C-Arm systems during the opening day of Arab Health 2016, the Middle East region's largest healthcare industry event, which runs from January 25 to January 28, 2016 at the Dubai International Convention and Exhibition Centre (DICEC). The company is a global leader in the field of analogue X-ray accessories and is one of the top global companies in the field of radiation protection. Kiran remains committed to the field of radiology and its entry into the field of equipment is a step forward towards becoming a holistic radiology focused organization.

The last one year has witnessed intense R&D activities within Kiran, and that is demonstrated by the series of new product launches over the past few months, that included the launch of Cathlab Pro radiation protection gloves specifically designed for interventional use, radiation protection apparel specifically designed for interventional procedures and high density anti-scatter grids for use with digital radiography equipment.

The C-Arm models in the pipeline include the Infinity Series – a high quality yet budget friendly C-Arm featuring 40 KHz generator with the options of 3.5 kW stationary anode and 5.0 kW rotating anode system with a 9 in image intensifier coupled with a top of the line image acquisition system. Software features include real time image acquisition, high end post processing features pre-prepared for cardiac applications. The system also offers digital zoom and network / USB connectivity. Moving up the ladder is the Elite Series that features cutting edge Italian mechanics with 1K x 1K image acquisition and state of the art user interface software.

Speaking on the occasion Dr. Velu, Founder and Chairman of Trivitron Group commented “Kiran has come a long way from being an accessories / radiation protection company to becoming a holistic radiology organization. Kiran has been one of the most respected brands in the world in the radiology space and the introduction of high quality radiology equipment at an affordable price point would further strengthen the extremely high brand perception that Kiran enjoys across the world. Though the products are yet to be launched, a lot of efforts have gone through with technology association and JV with IMD Italy and with Kiran’s own efforts.”

Read More »